ITR-251
/ Iteria Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 14, 2026
STRIVE-251: ITR-251 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=46 | Not yet recruiting | Sponsor: ITERIA BIOPHARMA, S.L.
New P1 trial • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1